Panel Discussion

Sunday, March 9, 2025

4:20 PM - 4:35 PM ET

Panel Moderator(s)

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Disclosure information not submitted.
JoAnn Lindenfeld, MD

Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States

Disclosure information not submitted.
Ileana L. Pina, MD, MPH

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

No relationships to disclose

Panel Discussant(s)

Scott M. Lilly, MD PhD

Professor
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States

Disclosure information not submitted.
Donna Mancini, MD

Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Disclosure(s): No financial relationships to disclose
MM

Martin Maron, MD

Director, HCM Center
Lahey Medical Center, Massachusetts, United States

Disclosure(s): Cytokinetics: Consultant (Ongoing); Edgewise: Consulting Fees (e.g., advisory boards) (Ongoing); imbria: Consultant (Ongoing)
Daniele Massera, MD

Associate Director, Hypertrophic Cardiomyopathy Program
NYU Langone Health
New York, New York, United States

No relationships to disclose
John C. Messenger, MD

Professor of Medicine
University of Colorado School of Medicine
Aurora, Colorado, United States

No relationships to disclose
CR

Charles D. Resor, MD

Interventional Cardiologist
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Matthew Sherwood, MD, MHS

System Director of Interventional Cardiology, Director of Structural Heart Program
Inova Schar Heart and Vascular Institute, Virginia, United States

No relationships to disclose
Yan Topilsky, MD

Head of Non Invasive Cardiology
Tel-Aviv Sourasky Medical Center

Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Terminated, December 12, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 12, 2024)

Disclosure(s):

William T. Abraham, MD: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)

JoAnn Lindenfeld, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)

Ileana L. Pina, MD, MPH: BOEHRINGER INGELHEIM IT.SpA.: advisory Board (Ongoing)

Scott M. Lilly, MD PhD: Cardiac Dimensions: Consultant (Ongoing); DASI Simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing)

Donna Mancini, MD: No financial relationships to disclose

Martin Maron, MD: Cytokinetics: Consultant (Ongoing); Edgewise: Consulting Fees (e.g., advisory boards) (Ongoing); imbria: Consultant (Ongoing)

Daniele Massera, MD: Chiesi: Consulting Fees (e.g., advisory boards) (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cytokinetics: Consulting Fees (e.g., advisory boards) (Terminated); Sanofi: Consulting Fees (e.g., advisory boards) (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Tenaya Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)

John C. Messenger, MD: Philips: Institutional grant support--University of Colorado SOM (Ongoing)

Yan Topilsky, MD: Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Terminated, December 12, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 12, 2024)